Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 12Carcinoma, Non-Small-Cell Lung 7Parkinson Disease 4, Autosomal Dominant Lewy Body 2Delirium 2Thromboembolism 1Small Cell Lung Carcinoma 1Respiratory Insufficiency 1Postoperative Complications 1Pneumonia 1Pleural Effusion, Malignant 1Pleural Effusion 1Neurotoxicity Syndromes 1Neoplasms 1Myocardial Infarction 1Metastatic Non-Squamous Non-Small Cell Lung Cancer 1Mesothelioma 1Lung Diseases 1Inoperable Stage III Non-small Cell Lung Cancer 1Emergence Delirium 1Arrhythmias, Cardiac 1Angina, Unstable 1Agnosia 1Acute Coronary Syndrome 1

Interventions

Thoracoscopy 4vandetanib 2Povidone-Iodine 2Cisplatin 2dalotuzumab 1X-Rays 1Ultrasonography 1Tyrosine Kinase Inhibitors 1Tissue Plasminogen Activator 1Thoracentesis 1Tenecteplase 1Surgical Procedures, Operative 1Saline Solution 1Receptors, Vascular Endothelial Growth Factor 1Pleurodesis 1Pemetrexed 1Octreotide 1Naproxen 1Hyperthermic Intraperitoneal Chemotherapy 1Gemcitabine 1Fentanyl 1Diclofenac 1Deoxyribonucleases 1Dasatinib 1Darbepoetin alfa 1Clinical Laboratory Techniques 1Chest Tubes 1Cdc25C phosphatase (211-221) 1Catheters, Indwelling 1Biomarkers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pleural Effusion × Saline Solution × Thoracic × Clear all
NCT01580618 2026-04-14

Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy

Kaiser Permanente

Phase 2/3 Terminated
20 enrolled 11 charts
Thoracic

Neoplasms, Pleural Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡